Cargando…
Adiposity is the Crucial Enhancer of COVID-19
Autor principal: | Yanai, Hidekatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430889/ https://www.ncbi.nlm.nih.gov/pubmed/32849972 http://dx.doi.org/10.14740/cr1118 |
Ejemplares similares
-
A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients
por: Yanai, Hidekatsu
Publicado: (2020) -
Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries
por: Yanai, Hidekatsu
Publicado: (2020) -
Bofutsushosan Significantly Ameliorated Betamethasone-Induced Cushing’s Syndrome
por: Yanai, Hidekatsu
Publicado: (2018) -
Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu
Publicado: (2021) -
COVID-19: the crucial role of the nose
por: Gamerra, Mario, et al.
Publicado: (2020)